AKT1 and colorectal cancer: found that APS downregulates PD-L1 protein levels by inhibiting the AKT/mToR/p70S6K axis, thereby enhancing the immune capacity of 4T1 (mouse BC) and CT26 (mouse colorectal cancer) cells (150) (Table 5).